There May Be Underlying Issues With The Quality Of Macrogen's (KOSDAQ:038290) Earnings
Apr 03
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Clinical Research and Equipment Industry Analysis
UpdatedMay 03, 2026
DataAggregated Company Financials
Companies29
- 7D-4.1%
- 3M-14.5%
- 1Y-2.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 4.1%, driven by a pullback from Samsung BiologicsLtd of 3.8%. Meanwhile, Curiox Biosystems actually outperformed within the industry, gaining 13% in the last week. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 03 May 2026 | ₩85.8t | ₩5.7t | ₩1.5t | 38.8x | 55.5x | 15x |
| Tue, 31 Mar 2026 | ₩89.5t | ₩5.4t | ₩1.5t | 17.2x | 60.4x | 16.5x |
| Thu, 26 Feb 2026 | ₩98.3t | ₩5.4t | ₩1.5t | 20.5x | 65x | 18.2x |
| Sat, 24 Jan 2026 | ₩99.6t | ₩5.4t | ₩1.5t | 15.8x | 65.9x | 18.4x |
| Mon, 22 Dec 2025 | ₩96.3t | ₩6.4t | ₩1.5t | 17.2x | 64.4x | 15.1x |
| Wed, 19 Nov 2025 | ₩104.1t | ₩5.8t | ₩1.2t | 16.7x | 87.2x | 17.8x |
| Fri, 17 Oct 2025 | ₩94.4t | ₩5.8t | ₩1.2t | 16.2x | 79.6x | 16.2x |
| Sun, 14 Sep 2025 | ₩89.4t | ₩5.8t | ₩1.2t | 14.6x | 75.4x | 15.3x |
| Tue, 12 Aug 2025 | ₩88.4t | ₩5.7t | ₩1.2t | 16.6x | 72.2x | 15.6x |
| Thu, 10 Jul 2025 | ₩83.9t | ₩5.6t | ₩1.2t | 15.7x | 68.2x | 15x |
| Sat, 07 Jun 2025 | ₩82.4t | ₩5.6t | ₩1.2t | 15.4x | 66.8x | 14.7x |
| Mon, 05 May 2025 | ₩87.4t | ₩5.2t | ₩1.0t | 18.2x | 85.3x | 16.7x |
| Wed, 02 Apr 2025 | ₩83.7t | ₩5.2t | ₩1.0t | 17.6x | 81.3x | 16x |
| Fri, 28 Feb 2025 | ₩91.1t | ₩5.2t | ₩996.4b | 12.9x | 91.4x | 17.5x |
| Sun, 26 Jan 2025 | ₩86.6t | ₩5.0t | ₩965.6b | 12.9x | 89.6x | 17.3x |
| Tue, 24 Dec 2024 | ₩75.2t | ₩5.0t | ₩965.6b | 13x | 77.9x | 15x |
| Thu, 21 Nov 2024 | ₩74.8t | ₩4.8t | ₩885.3b | 16x | 84.5x | 15.4x |
| Sat, 19 Oct 2024 | ₩84.8t | ₩4.8t | ₩885.3b | 14.3x | 95.8x | 17.5x |
| Mon, 16 Sep 2024 | ₩77.4t | ₩4.8t | ₩885.3b | 14x | 87.5x | 16x |
| Wed, 14 Aug 2024 | ₩73.9t | ₩4.5t | ₩731.7b | 15.3x | 101x | 16.3x |
| Fri, 12 Jul 2024 | ₩64.7t | ₩4.5t | ₩731.7b | 18.6x | 88.5x | 14.3x |
| Sun, 09 Jun 2024 | ₩59.4t | ₩4.6t | ₩689.6b | 19.2x | 86.1x | 12.9x |
| Tue, 07 May 2024 | ₩60.7t | ₩4.4t | ₩635.1b | 19.8x | 95.6x | 13.9x |
| Thu, 04 Apr 2024 | ₩64.3t | ₩4.7t | ₩656.9b | 18.9x | 97.9x | 13.8x |
| Sat, 02 Mar 2024 | ₩60.7t | ₩4.5t | ₩714.4b | 34.6x | 85x | 13.4x |
| Mon, 29 Jan 2024 | ₩60.8t | ₩4.5t | ₩714.4b | 34.5x | 85.1x | 13.4x |
| Wed, 27 Dec 2023 | ₩57.3t | ₩4.5t | ₩721.5b | 32.7x | 79.4x | 12.6x |
| Fri, 24 Nov 2023 | ₩57.0t | ₩4.6t | ₩742.0b | 22.5x | 76.9x | 12.5x |
| Sun, 22 Oct 2023 | ₩55.3t | ₩4.4t | ₩660.9b | 27.1x | 83.7x | 12.6x |
| Tue, 19 Sep 2023 | ₩58.4t | ₩4.4t | ₩660.9b | 30.1x | 88.4x | 13.3x |
| Thu, 17 Aug 2023 | ₩61.4t | ₩4.2t | ₩673.4b | 28.7x | 91.1x | 14.6x |
| Sat, 15 Jul 2023 | ₩58.0t | ₩4.2t | ₩673.4b | 29.1x | 86.2x | 13.8x |
| Mon, 12 Jun 2023 | ₩62.3t | ₩4.2t | ₩666.5b | 31.4x | 93.5x | 14.7x |
| Wed, 10 May 2023 | ₩61.7t | ₩4.1t | ₩626.3b | 27.6x | 98.6x | 15.1x |
Price to Earnings Ratio
98.6x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 55.5x which is lower than its 3-year average PE of 82.4x.
- The industry is trading close to its 3-year average PS ratio of 15.1x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have grown 35% per year over the last three years.
- Revenues for these companies have grown 12% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does South Korean Clinical Research and Equipment compare with similar industries?
| KR Market | 1.55% | |
| Healthcare | -3.37% | |
| Life Sciences | -4.08% | |
| Clinical Research and Equipment | -4.08% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A445680 Curiox Biosystems | ₩102.10k | 12.7% +₩196.9b | 321.9% | PS339.3x | |
| A039860 NanoEntek | ₩6.85k | 22.1% +₩47.2b | 100.3% | PE165.1x | |
| A464490 QuadMedicine | ₩13.38k | 1.1% +₩1.7b | n/a | PS14.4x | |
| A383930 DT&CRO | ₩3.49k | 0.1% +₩63.9m | -38.7% | PS0.9x |